Prevalence of ExoY Activity in
ExoY
Pseudomonas aeruginosa
cGMP
cystic fibrosis
nucleotidyl cyclase
Journal
Frontiers in microbiology
ISSN: 1664-302X
Titre abrégé: Front Microbiol
Pays: Switzerland
ID NLM: 101548977
Informations de publication
Date de publication:
2021
2021
Historique:
received:
09
02
2021
accepted:
30
07
2021
entrez:
22
10
2021
pubmed:
23
10
2021
medline:
23
10
2021
Statut:
epublish
Résumé
ExoY is among the effectors that are injected by the type III secretion system (T3SS) of
Identifiants
pubmed: 34675890
doi: 10.3389/fmicb.2021.666097
pmc: PMC8524455
doi:
Types de publication
Journal Article
Langues
eng
Pagination
666097Informations de copyright
Copyright © 2021 Silistre, Raoux-Barbot, Mancinelli, Sangouard, Dupin, Belyy, Deruelle, Renault, Ladant, Touqui and Mechold.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Curr Protein Pept Sci. 2012 Dec;13(8):831-42
pubmed: 23305368
J Infect Dis. 2003 Dec 1;188(11):1695-706
pubmed: 14639541
Cell Microbiol. 2005 Nov;7(11):1635-46
pubmed: 16207250
Proc Natl Acad Sci U S A. 2000 Apr 25;97(9):4885-90
pubmed: 10758151
J Bacteriol. 2019 Jun 10;201(13):
pubmed: 31010903
J Natl Cancer Inst. 1973 Nov;51(5):1417-23
pubmed: 4357758
Mol Biol Cell. 2008 Dec;19(12):5279-88
pubmed: 18829863
Transl Res. 2008 Dec;152(6):257-64
pubmed: 19059160
J Biol Chem. 2012 Jul 20;287(30):25407-18
pubmed: 22637478
J Bacteriol. 1994 Jul;176(13):3832-38
pubmed: 8021164
PLoS Pathog. 2008 Apr 04;4(4):e1000037
pubmed: 18389058
Handb Exp Pharmacol. 2017;238:67-85
pubmed: 28181005
Nat Commun. 2014 Oct 07;5:5105
pubmed: 25290234
J Biol Chem. 2018 Dec 21;293(51):19785-19796
pubmed: 30377256
FASEB J. 2020 Jul;34(7):9156-9179
pubmed: 32413239
Mol Microbiol. 2006 Nov;62(3):631-40
pubmed: 16995895
Cell Mol Life Sci. 2014 May;71(10):1927-41
pubmed: 23974244
FEBS J. 2017 Oct;284(20):3392-3403
pubmed: 28815941
Microbiology (Reading). 2001 Oct;147(Pt 10):2659-2669
pubmed: 11577145
Infect Immun. 2005 Mar;73(3):1706-13
pubmed: 15731071
Pathogens. 2015 Mar 02;4(1):66-89
pubmed: 25738646
Open Biol. 2018 Jan;8(1):
pubmed: 29386405
Nat Commun. 2016 Dec 05;7:13582
pubmed: 27917880
J Bacteriol. 2005 Jun;187(11):3898-902
pubmed: 15901720
J Bacteriol. 2008 Apr;190(8):2726-38
pubmed: 18039770
Cancer Res. 1985 Mar;45(3):1187-97
pubmed: 2578876
Am J Physiol Lung Cell Mol Physiol. 2020 Aug 1;319(2):L380-L390
pubmed: 32579398
Antimicrob Agents Chemother. 2010 May;54(5):1988-99
pubmed: 20176902
Crit Care Med. 2002 Mar;30(3):521-8
pubmed: 11990909
Infect Immun. 2017 Aug 18;85(9):
pubmed: 28652310
J Clin Microbiol. 2004 Nov;42(11):5229-37
pubmed: 15528719
Microbiologyopen. 2013 Dec;2(6):1010-23
pubmed: 24214409
Biochem Biophys Res Commun. 2014 Jul 18;450(1):870-4
pubmed: 24971548
J Immunol. 2012 Feb 15;188(4):1884-95
pubmed: 22250085
Microbiology (Reading). 2015 Oct;161(10):1961-1977
pubmed: 26253522
Methods Enzymol. 2002;350:87-96
pubmed: 12073338
Biomed Res Int. 2018 Sep 10;2018:5810767
pubmed: 30276212
Sci Signal. 2020 Jan 14;13(614):
pubmed: 31937566
PLoS One. 2018 Nov 12;13(11):e0206133
pubmed: 30419035
FEMS Microbiol Lett. 2018 Jul 1;365(14):
pubmed: 29897457
PLoS One. 2015 Dec 29;10(12):e0145708
pubmed: 26713879
Nucleic Acids Res. 2016 Jan 4;44(D1):D646-53
pubmed: 26578582
Toxins (Basel). 2020 Jun 04;12(6):
pubmed: 32512716
Trends Pharmacol Sci. 2016 Sep;37(9):734-749
pubmed: 27344210
Infect Immun. 2005 Mar;73(3):1695-705
pubmed: 15731070
J Bacteriol. 1997 Nov;179(22):7165-8
pubmed: 9371466
Infect Immun. 2007 Mar;75(3):1089-98
pubmed: 17178785
J Clin Microbiol. 2003 Aug;41(8):3526-31
pubmed: 12904350
J Med Microbiol. 2010 Aug;59(Pt 8):881-890
pubmed: 20430902
Proc Natl Acad Sci U S A. 1998 Nov 10;95(23):13899-904
pubmed: 9811898